|
|
|
Volumn 330, Issue 7485, 2005, Pages 255-256
|
|
Sentinel systems are needed for long term adverse drug reactions [5]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ROFECOXIB;
LACTONE;
SULFONE;
CARDIOVASCULAR DISEASE;
CASE CONTROL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DATA BASE;
DRUG APPROVAL;
DRUG COST;
DRUG RESEARCH;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
CHEMICALLY INDUCED DISORDER;
COST BENEFIT ANALYSIS;
NOTE;
ORGANIZATION AND MANAGEMENT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CARDIOVASCULAR DISEASES;
COST-BENEFIT ANALYSIS;
DRUG APPROVAL;
HUMANS;
LACTONES;
SULFONES;
|
|
EID: 13244269979
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (1)
|
|
References (3)
|
